The charity said the benefit has so far raised nearly US$300 million for its research programs on Aids. Read more at ...

One-time Amtagvi Treatment Demonstrated Durable Responses and a Five-year Overall Survival Rate of 20%. Five-year Follow Up is Unprecedented for Any Therapy in Patients with Advan ...

An oral presentation at ASCO & EHA Congress from the CARTITUDE-1 study highlighting heavily pre-treated patients that remain alive and progression-free for more than 5 years after a single CARVYKTI® ...

Antimicrobial drug developer HOOKIPA Pharma (NASDAQ:HOOK) announced Thursday that Gilead Sciences (NASDAQ:GILD) has agreed to ...

Kick streamer Wes "Wesbtw" has become the centre of controversy after faking a diagnosis of Human Immunodeficiency Virus (HIV) contraction during a broadcast on Kick.

In a fascinating blend of cutting-edge science and nature, researchers working on AIDS treatments have developed an unusual ...

Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the “Company”), comments on the new COVID Vaccine policy adopted by the US FDA.

FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.

As part of activities marking its 69th anniversary, the Nigerian Navy has organised a Medical Rhapsody programme in ...

The World Health Organisation (WHO) plans to prequalify ‘lenacapavir’ for the treatment and prevention of Human ...